{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:50:40Z","timestamp":1791924640157,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["IP COVID-19 893"],"award-info":[{"award-number":["IP COVID-19 893"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.biopha.2022.113201","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T02:30:23Z","timestamp":1653618623000},"page":"113201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"],"prefix":"10.1016","volume":"152","author":[{"given":"Mauro G.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo R.","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"P\u00e9rez Duhalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana M.","family":"Cela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Gonzales Maglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Brizzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter G.","family":"Espeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela M.","family":"Gironacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113201_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1042\/CS20200901","article-title":"Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease","volume":"134","author":"Ferrario","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2022.113201_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3389\/fphar.2020.01154","article-title":"ADAM17-Mediated shedding of inflammatory cytokines in hypertension","volume":"11","author":"de Queiroz","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113201_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576745","article-title":"ACE2\/ADAM17\/TMPRSS2 interplay may be the main risk factor for COVID-19","volume":"11","author":"Zipeto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113201_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2022.113201_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113201_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","article-title":"ACE2 elevation in severe COVID-19","volume":"203","author":"Reindl-Schwaighofer","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2022.113201_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252799","article-title":"Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients","volume":"16","author":"Kragstrup","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113201_bib8","doi-asserted-by":"crossref","first-page":"2003730","DOI":"10.1183\/13993003.03730-2020","article-title":"Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences","volume":"57","author":"Patel","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2022.113201_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijid.2020.11.184","article-title":"A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient","volume":"103","author":"Nagy","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113201_bib10","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/HYPERTENSIONAHA.120.15841","article-title":"Plasma angiotensin peptide profiling and ACE (angiotensin-converting enzyme)-2 activity in COVID-19 patients treated with pharmacological blockers of the renin-angiotensin system","volume":"76","author":"Kintscher","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.113201_bib11","doi-asserted-by":"crossref","first-page":"L213","DOI":"10.1152\/ajplung.00129.2021","article-title":"A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure","volume":"321","author":"Files","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2022.113201_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120324","article-title":"Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes","volume":"293","author":"Silva","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113201_bib13","doi-asserted-by":"crossref","unstructured":"K.B. Brosnihan, M.C. Chappell, Measurement of angiotensin peptides: HPLC-RIA, in: Methods Mol. Biol., Humana Press Inc., 2017, 81\u201399. \u3008https:\/\/doi.org\/10.1007\/978\u20131-4939\u20136625-7_7\u3009.","DOI":"10.1007\/978-1-4939-6625-7_7"},{"key":"10.1016\/j.biopha.2022.113201_bib14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.peptides.2007.06.016","article-title":"Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension","volume":"28","author":"Gironacci","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2022.113201_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1471-4159.2009.05912.x","article-title":"Angiotensin-(1-7) through AT2 receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway","volume":"109","author":"Lopez Verrilli","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2022.113201_bib16","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/v13091715","article-title":"SARS-CoV-2 infection modulates ACE2 function and subsequent inflammatory responses in swabs and plasma of COVID-19 patients","volume":"13","author":"Guti\u00e9rrez-Chamorro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2022.113201_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11906-018-0900-0","article-title":"Inflammation as a regulator of the renin-angiotensin system and blood pressure","volume":"20","author":"Satou","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.biopha.2022.113201_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fnins.2020.00650","article-title":"Interactions of the brain renin-angiotensin-system (RAS) and inflammation in the sensitization of hypertension","volume":"14","author":"Lytra","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2022.113201_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jmv.26479","article-title":"Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7","volume":"93","author":"Henry","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2022.113201_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ajh\/hpaa169","article-title":"Serum ACE2, angiotensin ii, and aldosterone levels are unchanged in patients With COVID-19","volume":"34","author":"Rieder","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2022.113201_bib21","doi-asserted-by":"crossref","unstructured":"B.M. Henry, S. Benoit, G. Lippi, J. Benoit, Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report, Prog. Cardiovasc. Dis., 63 (2020) 702. \u3008https:\/\/doi.org\/10.1016\/J.PCAD.2020.07.006\u3009.","DOI":"10.1016\/j.pcad.2020.07.006"},{"key":"10.1016\/j.biopha.2022.113201_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2217\/bmm-2021-0121","article-title":"The role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19","volume":"0","author":"Bibero\u01e7lu","year":"2021","journal-title":"Biomark. Med."},{"key":"10.1016\/j.biopha.2022.113201_bib23","doi-asserted-by":"crossref","first-page":"00848","DOI":"10.1183\/23120541.00848-2020","article-title":"Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients","volume":"7","author":"van Lier","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.biopha.2022.113201_bib24","doi-asserted-by":"crossref","first-page":"00114","DOI":"10.1183\/23120541.00114-2021","article-title":"Increased circulating levels of angiotensin-(1-7) in severely ill COVID-19 patients","volume":"7","author":"Valle Martins","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.biopha.2022.113201_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-021-03507-7","article-title":"Renin-angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report","volume":"25","author":"Eleuteri","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2022.113201_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12879-020-05619-x","article-title":"The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113201_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","article-title":"Dysregulation of ACE (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.113201_bib28","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3389\/fimmu.2021.625732","article-title":"Expression of ACE2, soluble ACE2, angiotensin I, angiotensin II and angiotensin-(1-7) is modulated in COVID-19 patients","volume":"12","author":"Osman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113201_bib29","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1002\/jmv.27144","article-title":"Soluble angiotensin\u2010converting enzyme 2 is transiently elevated in COVID\u201019 and correlates with specific inflammatory and endothelial markers","volume":"93","author":"Lundstr\u00f6m","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2022.113201_bib30","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/cells10102755","article-title":"Quantifying renin-angiotensin-system alterations in COVID-19","volume":"10","author":"Pucci","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113201_bib31","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113201_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation Is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.113201_bib33","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms.","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.113201_bib34","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: The good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.113201_bib35","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.3390\/ijms22168423","article-title":"Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality","volume":"22","author":"Palacios","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113201_bib36","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"Yeung","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113201_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.16795","article-title":"Angiotensin type 1 receptor-dependent internalization of SARS-CoV-2 by angiotensin-converting enzyme 2","volume":"77","author":"Ogunlade","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.113201_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2022.113201_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imm.13223","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China","volume":"160","author":"Tan","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2022.113201_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155507","article-title":"IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19","volume":"143","author":"Luporini","year":"2021","journal-title":"Cytokine"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222200590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222200590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:25:05Z","timestamp":1791923105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222200590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"alternative-id":["S075333222200590X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113201","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113201"}}